SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1186Mike: Thanks for the clarification. Arniearnie h-6/14/2001
1185The Russell 3000 includes the 2000 small caps and the 1000 higher cap stocks. MMichael Casey-6/12/2001
1184Thanks. Your reference says it is the Russell 3000 rather than the 2000.arnie h-6/11/2001
1183PARS added to Russell 2000 index. There were a lot of changes to the index andMichael Casey-6/9/2001
1182Patience rewarded? Up 14 per cent today, capping nice week's run. It's LLLefty-6/1/2001
1181moving on target Pharmos Corporation Reports 2001 First Quarter Results Developleigh aulper-5/1/2001
1180leigh, thanks for posting the interview.wolfdog2-3/30/2001
1179You've got to love Haim. The last time they let him loose he helped drive thLLLefty-3/28/2001
1178The old codger loves start-ups Aviva Mishmari 26.03.2001 16:16 As one of the mleigh aulper-3/28/2001
1177Pharmos Corporation Reports 2000 Results; Expanded R&D Supported by 55% Incrleigh aulper-3/7/2001
11761. Phase III could be successful with as little of 300 patients, to ensure statiCacaito-1/19/2001
1175madharry, I think you are focused on the wrong problem with regard to PARS. Manwolfdog2-1/17/2001
1174The way Pharmos is doing their clinical study is required for FDA approval. TheFilbert-1/17/2001
1173Also - and I certainly have no practical experience in this but the difficulty iMadharry-1/17/2001
1172I do not know how they conducted the trials . I would like to be convinced that Madharry-1/17/2001
1171Madharry, how do you think they conducted the P2 trials? With monkeys? If anytwolfdog2-1/17/2001
1170When the options are presented clearly and without guile then I'm sure most Noel de Leon-1/17/2001
1169I really am curious as to how they can do this test. Imagine it is your relativeMadharry-1/16/2001
1168Madharry, if approval is needed it would be gotten from the next of kin. As twolfdog2-1/16/2001
1167Could someone enlighten me as to how this study is to work? my lack of understanMadharry-1/16/2001
1166Very impressive, Pars full 860 subjects phase III, with 70 centers, first 40 in Cacaito-1/10/2001
1165Pharmos Starts Phase III Trial Of Brain Injury Drug By JOHN SHIPMAN Of Dleigh aulper-1/10/2001
1164Lifescience 2000, a Redchip Virtual Investor Conference to be Broadcast by Invesleigh aulper-12/12/2000
1163Pharmos Corporation Invites You to Join Its Third Quarter Conference Call On theleigh aulper-11/14/2000
1162ISELIN, N.J., Nov. 14 /PRNewswire/ -- Pharmos Corporation (Nasdaq: PARS and Easdleigh aulper-11/14/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News